Sermorelin Peptide vs Tesamorelin: Key Differences Explained

Sermorelin and tesamorelin are both lab-made versions of growth hormone-releasing hormone (GHRH). Both signal the pituitary gland to release the body's own growth hormone. In the sermorelin peptide vs tesamorelin question, the real differences are molecular structure, regulatory status and what each one has actually been studied and approved for.

The short version: tesamorelin is an FDA-approved prescription medicine with one narrow, labeled use. Sermorelin, as prescribed through ShopMedRx, is a compounded medication, and compounded medications are not FDA-approved. They are not interchangeable, and which one (if either) is appropriate is a decision for a licensed clinician. This post is for adults 18 and older and is general education, not medical advice.

Sermorelin peptide vs tesamorelin at a glance

This table sums up the main points. Details follow below.

Question	Sermorelin	Tesamorelin
What it is	A shorter fragment of GHRH, the first 29 amino acids[10]	A modified version of the full 44-amino-acid GHRH[2]
How it acts	Binds the GHRH receptor on the pituitary	Binds the GHRH receptor on the pituitary[2]
FDA status	Compounded versions are not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.[4]	FDA-approved prescription drug with one labeled use[1]
Labeled use	No FDA-approved use for compounded sermorelin	Reduction of excess abdominal fat in adults with HIV and lipodystrophy[1]
Approved for general weight loss?	No	No[1]
Given by	Injection under the skin, as directed by a clinician	Injection under the skin[1]
Prescription needed	Yes	Yes

How both peptides work

Your hypothalamus releases GHRH, which tells the pituitary to release growth hormone. Growth hormone then prompts the liver to make IGF-1, and IGF-1 feeds back to dial the signal down. Peptides that act on the GHRH receptor work upstream of growth hormone and, according to a published tesamorelin trial report, preserve that IGF-1 feedback.^[2]

That is why both drugs depend on a pituitary gland that works normally. They prompt your own gland to act. They do not supply growth hormone themselves.

Tesamorelin vs sermorelin: the structural difference

Sermorelin copies only the first 29 amino acids of natural GHRH, the part that activates the receptor.^[10] On its own, a GHRH-type peptide is broken down quickly in the blood. One pharmacology summary puts sermorelin's half-life at roughly 10 to 12 minutes.^[10]

Tesamorelin keeps all 44 amino acids and adds a small chemical group at one end. In a peer-reviewed trial report, that change is described as improving stability in serum compared with natural GHRH.^[2] This is the main reason people say the two behave differently, but structure alone does not tell you which one is right for a person.

What tesamorelin is approved for, and what it is not

The FDA label describes tesamorelin as a growth hormone-releasing factor analog indicated to reduce excess abdominal fat in HIV-infected adults with lipodystrophy.^[1] That is a specific medical condition, not belly fat in general.

The approval rests on two multicenter, randomized, double-blind, placebo-controlled studies in HIV-infected patients with lipodystrophy and excess abdominal fat.^[3] What those studies found applies to that group. Individual results vary, and the findings should not be read as applying to people without that condition.

The label also includes a limitation: long-term cardiovascular safety, and any long-term cardiovascular benefit, have not been studied and are not known.^[3] Prescribers are told to think carefully about continuing treatment in people who do not show a clear response.^[3]

Where sermorelin stands today

Sermorelin acetate has a regulatory history. An earlier sermorelin product was reviewed by the FDA, and the agency has had a summary report prepared on sermorelin acetate.^[8] That product is no longer on the U.S. market. Today, sermorelin is dispensed by licensed pharmacies as a compounded medication.

The FDA explains that compounded drugs are not FDA-approved, and that the agency does not review them for safety, effectiveness or quality before they are sold.^[4][5] A clinician can still decide that a compounded medicine is appropriate for a particular patient. That is one reason a real clinical review matters, and why you should not treat any compounded product as having been proven for a specific goal.

We make no claims about energy, aging, performance or disease prevention for sermorelin. If a clinician prescribes it, it is a clinical judgment for that person, not a promise of any result. You can read how our program works on the Peak Recovery Injection (sermorelin) page.

Is tesamorelin better than sermorelin?

"Better" depends on the question being asked. Tesamorelin has controlled trial data and an FDA-approved use in a defined group of adults with HIV-associated lipodystrophy.^[1] Sermorelin has no current FDA-approved use as a compounded medication. Comparing them on a single measure would be misleading, because they were never tested head to head for the same purpose in the sources we reviewed.

So if you are asking "sermorelin or tesamorelin" for a general goal, the honest answer is that neither is approved for general weight loss, and the choice is not yours or ours to make from a blog post. A licensed clinician looks at your health history, labs and goals, then decides whether any prescription is appropriate. Research on growth hormone secretagogues and body composition is still developing; one review in PubMed Central looks at it in men with low testosterone.^[9]

If body composition is on your mind more broadly, our post on creatine and muscle on a GLP-1 covers a different topic with a related theme, and is worth discussing with a clinician too.

Sermorelin vs HGH: why they are different medicines

Searches for "sermorelin vs HGH" or "HGH vs sermorelin" often assume the two act the same way. They do not. Human growth hormone (somatropin) is the hormone itself. Sermorelin is a signal that asks the pituitary to release its own hormone.

Researchers note that GHRH-type peptides keep the IGF-1 negative feedback loop in place.^[2] Growth hormone given directly works differently because it bypasses that step. This is a difference in mechanism only. It does not mean one is safer, stronger or a stand-in for the other. Growth hormone is a separate prescription medicine with its own FDA labeling, and a clinician would weigh that separately.

Sermorelin vs ipamorelin

People also search "sermorelin vs ipamorelin." Ipamorelin is an investigational drug that is not approved by the FDA, and we do not cover it in this post.

Can you use sermorelin and tesamorelin together?

Both act on the same receptor, so it is not obvious that taking them together adds anything. We did not find evidence in the sources for this post supporting the pairing. Do not combine them on your own. If you are already taking one, tell your clinician before any change.

Safety: key risks and who should not use these peptides

Tesamorelin

• Blood sugar: The label notes that glucose intolerance or diabetes may develop with tesamorelin.^[1] A trial protocol describing the earlier studies notes a risk of high blood sugar in the first weeks, which settled over several months.^[3]
• Common effects: In earlier placebo-controlled studies, injection-site redness (8.5% vs 2.7%), injection-site itching (7.6% vs 0.8%) and swelling in the limbs (6.1% vs 2.3%) were more common with tesamorelin than placebo.^[3] Individual results vary.
• Heart health: Long-term cardiovascular effects are unknown.^[3]
• The full label lists more warnings and situations where it should not be used. Read it with your prescriber.^[1]

Sermorelin

• Reported side effects include reactions at the injection site, and some people report other effects such as flushing or headache. See Mayo Clinic's drug information and the label summary for the full list.^[6][7]
• People with a known allergy to sermorelin or to anything in the formulation should not use it.
• Tell your clinician about thyroid conditions, pituitary problems, pregnancy or breastfeeding, and every medicine and supplement you take.
• Because compounded products are not FDA-reviewed, ask which licensed pharmacy fills the prescription.^[4]

Seek urgent care for signs of a serious allergic reaction, such as swelling of the face or throat or trouble breathing. For any other new symptom, contact your clinician.

Questions to bring to a licensed clinician

Whether you are weighing tesamorelin or sermorelin, or neither, go in with specific questions. A clinician can answer them for your situation.

1. What condition or goal are we treating, and is a prescription medicine appropriate for it?
2. Does this medicine have an FDA-approved use, or is it compounded and not FDA-approved?
3. Which tests, such as blood sugar or IGF-1, would be checked before and during treatment?
4. Do my other conditions or medicines change the risks?
5. How will we decide whether to continue, change or stop?
6. Which licensed pharmacy fills the prescription, and how should I store it?

Frequently asked questions

What is the main difference between sermorelin and tesamorelin?

Both signal the pituitary to release growth hormone. Sermorelin is a 29-amino-acid fragment of GHRH, while tesamorelin is a modified 44-amino-acid version. Tesamorelin is FDA-approved for a narrow use in adults with HIV and lipodystrophy, and compounded sermorelin is not FDA-approved.^[1][10]

Is tesamorelin better than sermorelin?

Neither is better across the board. They have different regulatory status and were studied for different things, so a direct ranking would not be accurate. A licensed clinician decides whether either is appropriate for you.

Is sermorelin the same as HGH?

No. HGH is growth hormone itself, while sermorelin prompts the pituitary to release its own. They are separate medicines, and one is not a stand-in for the other.

Can you take sermorelin and tesamorelin together?

We found no evidence in our sources that supports taking both, and they act on the same receptor. Do not combine them on your own. Ask your clinician before changing any treatment.

Is tesamorelin approved for weight loss?

No. The FDA label covers reducing excess abdominal fat in HIV-infected adults with lipodystrophy.^[1] It is not a general weight-loss drug.

Do I need a prescription for sermorelin?

Yes. Sermorelin is prescription-only. A licensed clinician reviews your health assessment and decides whether a prescription is appropriate, and approval is not guaranteed.

Talk to a licensed clinician

If you want to know whether sermorelin could be appropriate for you, complete a short online health assessment. An independent, licensed clinician reviews it and decides whether a prescription makes sense. If one is prescribed, a licensed U.S. partner pharmacy fills it. Do not start, stop or change any treatment without talking to a clinician.

Check if you qualify

By the ShopMedRx team.

Important information

• This article is for general education and is not medical advice. Talk to a licensed clinician before starting, stopping or changing any treatment.
• All medications available through ShopMedRx are prescription only and are prescribed only if appropriate after a licensed clinician's review.
• Some medications we offer are compounded. Compounded medications are not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality before they are marketed.
• Individual results vary. Nothing in this article promises a specific result.
• Prescriptions are written by independent, licensed clinicians through OpenLoop Health and filled by licensed U.S. partner pharmacies.

Sources

1. U.S. FDA. Tesamorelin for injection: full prescribing information (indications and usage). U.S. FDA, 2019. https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022505Orig1s010lbl.pdf
2. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: a randomized, placebo-controlled trial. PubMed Central. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5472315/
3. U.S. FDA. Tesamorelin for injection: prescribing information (2013 version, limitations of use and clinical studies). U.S. FDA. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022505s004lbl.pdf. Also: Growth hormone releasing hormone analog to improve nonalcoholic fatty liver disease and associated cardiovascular risk, study protocol (risks and discomforts section). ClinicalTrials.gov, NCT03375788. https://cdn.clinicaltrials.gov/large-docs/88/NCT03375788/Prot_SAP_000.pdf
4. U.S. FDA. Understanding the risks of compounded drugs. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/understanding-risks-compounded-drugs
5. U.S. FDA. Consumer and health care professional information on compounded drugs. U.S. Food and Drug Administration. https://www.fda.gov/drugs/human-drug-compounding/consumer-and-health-care-professional-information
6. Mayo Clinic. Sermorelin (injection route): side effects and dosage. Mayo Clinic. https://www.mayoclinic.org/drugs-supplements/sermorelin-injection-route/description/drg-20065923
7. RxList. Sermorelin acetate: side effects, warnings and precautions (summary of prescribing information). RxList. https://www.rxlist.com/sermorelin-acetate-drug.htm
8. Summary report: sermorelin acetate (report prepared for the U.S. FDA). University of Maryland Health Sciences and Human Services Library archive. https://archive.hshsl.umaryland.edu/server/api/core/bitstreams/a2397a31-6114-4797-969e-f7709ac7cc57/content
9. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC7108996/
10. Peptide Journal. Sermorelin vs. tesamorelin: GHRH analogs (structure and pharmacokinetics summary). https://www.peptidejournal.org/compare/sermorelin-vs-tesamorelin-ghrh-analogs